Profile data is unavailable for this security.
About the company
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes seven branded and two authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved by the United States Food and Drug Administration (FDA) for sale, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox and Luxamend. It sells two authorized generic products, including sulconazole nitrate cream and solution and doxycycline hyclate immediate release 50mg tablets. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne.
- Revenue in USD (TTM)79.18m
- Net income in USD-3.85m
- Incorporated2014
- Employees58.00
- LocationJourney Medical Corp9237 E Via De Ventura Blvd.Suite 105, Suite 105SCOTTSDALE 85258United StatesUSA
- Phone+1 (480) 434-6670
- Fax+1 (302) 531-3150
- Websitehttps://journeymedicalcorp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aadi Bioscience Inc | 23.84m | -68.83m | 47.02m | 75.00 | -- | 0.5198 | -- | 1.97 | -2.55 | -2.55 | 0.8848 | 3.68 | 0.1692 | 0.6021 | 4.54 | 267,865.20 | -48.86 | -50.25 | -56.39 | -56.15 | 87.70 | -- | -288.72 | -473.97 | 4.86 | -- | 0.00 | -- | 60.06 | 3.85 | -8.68 | -- | 153.54 | -- |
| Carmell Corp | 0.00 | -16.88m | 47.27m | 9.00 | -- | 2.13 | -- | -- | -1.53 | -1.46 | 0.00 | 1.07 | -- | -- | -- | 0.00 | -- | -- | -- | -- | 58.60 | -- | -- | -- | -- | -194.46 | 0.0495 | -- | -- | -- | -75.70 | -- | -- | -- |
| Reviva Pharmaceuticals Holdings, Inc. | 0.00 | -39.26m | 47.74m | 15.00 | -- | 8.35 | -- | -- | -1.66 | -1.66 | 0.00 | 0.2048 | 0.00 | -- | -- | 0.00 | -184.22 | -- | -507.01 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -38.92 | -- | -- | -- |
| Correlate Energy Corp | 7.56m | -12.79m | 48.15m | 19.00 | -- | -- | -- | 6.37 | -0.3554 | -0.3554 | 0.21 | -0.0877 | 2.22 | -- | 13.19 | 398,051.60 | -375.16 | -315.47 | -- | -- | 18.27 | 15.42 | -169.09 | -201.03 | -- | -0.7239 | 8.30 | -- | 122.20 | 46.12 | -78.54 | -- | -- | -- |
| Benson Hill Inc | 359.83m | -132.72m | 48.23m | 270.00 | -- | 0.7167 | -- | 0.134 | -0.7033 | -0.7082 | 1.90 | 0.3174 | 1.13 | 9.80 | 20.67 | 1,332,689.00 | -41.85 | -- | -49.16 | -- | 5.38 | 3.18 | -36.88 | -40.73 | 2.02 | -2.12 | 0.183 | -- | 24.16 | 156.43 | -11.58 | -- | 63.78 | -- |
| Dyadic International Inc | 2.26m | -7.85m | 48.53m | 7.00 | -- | 10.73 | -- | 21.52 | -0.2724 | -0.2724 | 0.0783 | 0.1547 | 0.1769 | -- | 4.51 | 322,197.20 | -61.58 | -36.82 | -73.50 | -39.85 | 38.24 | 22.47 | -348.00 | -410.16 | -- | -- | 0.5634 | -- | -1.07 | 17.48 | 30.20 | -- | -- | -- |
| Gain Therapeutics Inc | 55.18k | -22.27m | 48.56m | 29.00 | -- | 3.47 | -- | 880.03 | -1.74 | -1.74 | 0.0042 | 0.7761 | 0.0026 | -- | 0.2544 | 1,902.76 | -104.28 | -- | -132.41 | -- | -- | -- | -40,354.33 | -13,827.07 | -- | -- | 0.0432 | -- | -60.62 | 21.77 | -26.59 | -- | 13.96 | -- |
| Clene Inc. | 620.00k | -48.81m | 49.52m | 82.00 | -- | 11.61 | -- | 79.88 | -0.4764 | -0.4764 | 0.0053 | 0.0332 | 0.0146 | 2.11 | 9.76 | 7,560.98 | -114.91 | -39.43 | -233.02 | -47.32 | 78.71 | -- | -7,873.23 | -5,261.20 | 1.22 | -32.64 | 0.8641 | -- | 38.27 | -- | -65.47 | -- | -- | -- |
| Journey Medical Corp | 79.18m | -3.85m | 50.58m | 58.00 | -- | 3.44 | -- | 0.6388 | -0.3502 | -0.3502 | 4.19 | 1.05 | 0.8701 | 2.19 | 3.65 | 1,365,190.00 | -4.23 | -- | -10.51 | -- | 66.33 | -- | -4.87 | -- | 1.10 | 0.6863 | 0.4641 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
| Aligos Therapeutics Inc | 13.79m | -99.59m | 51.16m | 67.00 | -- | 0.8627 | -- | 3.71 | -1.51 | -1.51 | 0.1796 | 0.7592 | 0.1105 | -- | -- | 208,969.70 | -79.78 | -51.20 | -98.27 | -59.73 | -- | -- | -722.06 | -1,399.21 | -- | -- | 0.0037 | -- | 11.66 | -- | 8.71 | -- | -62.36 | -- |
| Moolec Science SA | 2.65m | -52.66m | 51.37m | 45.00 | -- | 5.07 | -- | 19.42 | -1.44 | -1.44 | 0.0766 | 0.2367 | -- | -- | -- | 58,780.00 | -- | -- | -- | -- | 2.92 | -- | -1,990.79 | -- | 0.2243 | -0.1889 | 0.2372 | -- | -- | -- | -1,044.02 | -- | -- | -- |
| Rockwell Medical Inc | 86.62m | -8.42m | 52.75m | 237.00 | -- | -- | -- | 0.609 | -0.3584 | -0.3584 | 3.33 | -- | -- | -- | -- | 365,485.20 | -- | -46.29 | -- | -65.38 | 10.59 | 4.66 | -9.72 | -36.51 | -- | -3.41 | -- | -- | 14.84 | 5.69 | 54.82 | -- | 76.21 | -- |
| America Great Health | 219.13k | -859.20k | 52.78m | 7.00 | -- | -- | -- | 240.88 | -0.00004 | -0.00004 | 0.00001 | -0.0002 | 0.6746 | 0.0721 | 18.16 | 31,304.29 | -265.62 | -543.96 | -- | -- | 95.92 | -247.36 | -393.74 | -1,193.55 | 0.035 | -1.37 | -- | -- | 95.23 | -- | 84.35 | -- | -- | -- |
| Modular Medical Inc | 0.00 | -16.76m | 54.23m | 37.00 | -- | 9.69 | -- | -- | -0.9653 | -0.9653 | 0.00 | 0.1805 | 0.00 | -- | -- | 0.00 | -224.40 | -168.16 | -262.22 | -209.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 25.51 | -- | 154.53 | -- |
Data as of May 17 2024. Currency figures normalised to Journey Medical Corp's reporting currency: US Dollar USD
11.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 305.61k | 2.44% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 261.00k | 2.09% |
| Acadian Asset Management LLCas of 31 Mar 2024 | 222.66k | 1.78% |
| American Money Management Corp.as of 31 Mar 2024 | 180.00k | 1.44% |
| EAM Investors LLCas of 31 Dec 2023 | 110.51k | 0.88% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2023 | 94.48k | 0.76% |
| Geode Capital Management LLCas of 31 Dec 2023 | 85.79k | 0.69% |
| Millennium Management LLCas of 31 Dec 2023 | 75.03k | 0.60% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 39.74k | 0.32% |
| NewEdge Advisors LLCas of 31 Dec 2023 | 36.59k | 0.29% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
